For a bacteriophage to be useful for phage therapy it must be both isolated from the
environment and shown to have certain characteristics beyond just killing strains of the …

The history of phage therapy started with its first clinical application in 1919 and continues its
development to this day. Phages continue to lack any market approval in Western medicine …

Virtually all studies of phage infections investigate bacteria growing exponentially in rich
media. In nature, however, phages largely encounter non-growing cells. Bacteria entering …

Growing antibiotic resistance and the broken antibiotic market have renewed interest in the
use of phages, a century-old therapy that fell into oblivion in the West after two decades of …

Netherton syndrome (NS) is a rare autosomal recessive disorder, characterized by a
classical triad of clinical features, including congenital ichthyosiform erythroderma …

Purpose The potential of aerosol phage therapy for treating lung infections has been
demonstrated in animal models and clinical studies. This work compared the performance of …

Use of bacterial viruses as antibacterial agents has a history nearly as long as the now 100-
year study of bacteriophages. Therapeutic phages are especially useful in the absence of …

The emerging occurrence of antibiotic-resistant bacterial pathogens leads to a recollection
of bacteriophage as antimicrobial therapeutics. This article presents a short overview of the …

For more than a century, bacteriophage (or phage) research has enabled some of the most
important discoveries in biological sciences and has equipped scientists with many of the …

Phage therapy is the use of bacterial viruses to reduce or eliminate bacterial infections. As
such, phage therapy has been employed clinically for approximately 100 years. It is …